Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Vaxil's ImMucin designated FDA orphan drug for multiple myeloma

June 23, 2015

New round of funding to support Batu Biologics' development of ValloVax

June 23, 2015

European Commission approves Opdivo for advanced melanoma

June 22, 2015

TapImmune gains additional funding

June 22, 2015

Pembrolizumab receives U.S. orphan drug status for gastric cancer

June 22, 2015

Admune Therapeutics starts phase I trial of hetIL-15 in metastatic cancers

June 19, 2015

OncoSec Medical starts phase II study of ImmunoPulse in HNSCC

June 19, 2015

SVN-2B peptide vaccination shows promise for gastrointestinal cancer

June 19, 2015

Clinical benefit seen with autologous T cells specific for HER2 and CMV in glioblastoma multiforme

June 18, 2015

Phase I/IIa results disclosed for therapeutic p16 HPV vaccine

June 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026